Graft-Versus-Host Disease - First stem cell drug approved in Canada

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Graft-versus-host disease is a common condition that can occur after an allogeneic bone marrow transplant, in which the transplanted material attacks the host's body, increasing the patient's susceptibility to infection. Though the disorder still hasn t any effective medical treatment, a drug (Prochymal) provided by a stem cell therapeutic company could show promise, being recently approved by Canadian health regulators. Learn more about the disease and its potential treatment in this book.

Product details

• Assisted by: Edward R. Miller-Jones (Editor), Edwar R Miller-Jones (Editor)
• Publisher: FastBook Publishing
• Languages: English
• Product format: Paperback / Softback
• Released: 25.05.2012
• EAN: 9786130133245
• ISBN: 978-613-0-13324-5
• No. of pages: 96
• Subject: Natural sciences, medicine, IT, technology > Medicine